Subscribe for the newsletter
Mobile Navigation
Subscribe for the Newsletter
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Directory
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
H.I.G. Capital
Sort By
Newest First
Sign in
1 / 1
1 / 1
Transaction
Mallinckrodt Agrees to Sell BioVectra Inc. to H.I.G. Capital for $250 Million
BIOVECTRA
PR-M09-19-NI-037
Sep 13, 2019
